(Boehringer Ingelheim) – Dr. Palmisano is a leading advocate for Boehringer Ingelheim who regularly engages with external stakeholders to support the industry and demonstrate its value to patients and policymakers. Her passion for pediatric therapies has also led her to participate in FDA dialogues on sound policies for pediatric drug development.
Joanne Palmisano, MD, FACP
